{"title":"吲哚菁绿负载 N 掺杂碳量子点纳米粒子用于黑色素瘤的有效光动力治疗和细胞成像:体外、体内和体外研究。","authors":"Hadiseh Mehravanfar, Nafiseh Farhadian, Khalil Abnous","doi":"10.1080/1061186X.2024.2358511","DOIUrl":null,"url":null,"abstract":"<p><p>N-doped carbon quantum dot (CQD) nanoparticle was prepared as a novel nanocarrier with excellent solubility, stability, and high quantum yield to overcome Indocyanine Green (ICG) obstacle in photodynamic therapy (PDT) with simultaneous cell imaging property. Cell culture study and <i>In vivo</i> assessments on the C57BL/6 mice containing melanoma cancer cells was performed. Results showed that CQD size after ICG loading slightly enhanced from 24.55 nm to 42.67 nm. Detection of reactive oxygen species (ROS) test demonstrated that CQD improved ICG photo-stability and ROS generation capacity upon laser irradiation. Cell culture study illustrated that ICG@CQD could decrease the survival rate of melanoma cancer cells of B16F10 cell line from 48% for pure ICG drug to 28% for ICG@CQD. Captured images by confocal microscopy approved more cellular uptake of ICG@CQD and more qualified cell imaging ability of the nanocarrier. <i>In vivo</i> assessments on the C57BL/6 mice containing melanoma cancer cells displayed the obvious inhibitory effect of the tumor growth for ICG@CQD in comparison to free ICG. <i>In vivo</i> fluorescence images confirmed that ICG@CQD accumulates remarkably more than free ICG in the tumor region. In conclusion, ICG@CQD is proposed as an innovative nanocarrier with great potential for PDT and diagnosis.</p>","PeriodicalId":15573,"journal":{"name":"Journal of Drug Targeting","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2024-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Indocyanine green-loaded N-doped carbon quantum dot nanoparticles for effective photodynamic therapy and cell imaging of melanoma cancer: <i>In vitro</i>, <i>ex vivo</i> and <i>in vivo</i> study.\",\"authors\":\"Hadiseh Mehravanfar, Nafiseh Farhadian, Khalil Abnous\",\"doi\":\"10.1080/1061186X.2024.2358511\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>N-doped carbon quantum dot (CQD) nanoparticle was prepared as a novel nanocarrier with excellent solubility, stability, and high quantum yield to overcome Indocyanine Green (ICG) obstacle in photodynamic therapy (PDT) with simultaneous cell imaging property. Cell culture study and <i>In vivo</i> assessments on the C57BL/6 mice containing melanoma cancer cells was performed. Results showed that CQD size after ICG loading slightly enhanced from 24.55 nm to 42.67 nm. Detection of reactive oxygen species (ROS) test demonstrated that CQD improved ICG photo-stability and ROS generation capacity upon laser irradiation. Cell culture study illustrated that ICG@CQD could decrease the survival rate of melanoma cancer cells of B16F10 cell line from 48% for pure ICG drug to 28% for ICG@CQD. Captured images by confocal microscopy approved more cellular uptake of ICG@CQD and more qualified cell imaging ability of the nanocarrier. <i>In vivo</i> assessments on the C57BL/6 mice containing melanoma cancer cells displayed the obvious inhibitory effect of the tumor growth for ICG@CQD in comparison to free ICG. <i>In vivo</i> fluorescence images confirmed that ICG@CQD accumulates remarkably more than free ICG in the tumor region. In conclusion, ICG@CQD is proposed as an innovative nanocarrier with great potential for PDT and diagnosis.</p>\",\"PeriodicalId\":15573,\"journal\":{\"name\":\"Journal of Drug Targeting\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2024-05-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Drug Targeting\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/1061186X.2024.2358511\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Drug Targeting","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/1061186X.2024.2358511","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Indocyanine green-loaded N-doped carbon quantum dot nanoparticles for effective photodynamic therapy and cell imaging of melanoma cancer: In vitro, ex vivo and in vivo study.
N-doped carbon quantum dot (CQD) nanoparticle was prepared as a novel nanocarrier with excellent solubility, stability, and high quantum yield to overcome Indocyanine Green (ICG) obstacle in photodynamic therapy (PDT) with simultaneous cell imaging property. Cell culture study and In vivo assessments on the C57BL/6 mice containing melanoma cancer cells was performed. Results showed that CQD size after ICG loading slightly enhanced from 24.55 nm to 42.67 nm. Detection of reactive oxygen species (ROS) test demonstrated that CQD improved ICG photo-stability and ROS generation capacity upon laser irradiation. Cell culture study illustrated that ICG@CQD could decrease the survival rate of melanoma cancer cells of B16F10 cell line from 48% for pure ICG drug to 28% for ICG@CQD. Captured images by confocal microscopy approved more cellular uptake of ICG@CQD and more qualified cell imaging ability of the nanocarrier. In vivo assessments on the C57BL/6 mice containing melanoma cancer cells displayed the obvious inhibitory effect of the tumor growth for ICG@CQD in comparison to free ICG. In vivo fluorescence images confirmed that ICG@CQD accumulates remarkably more than free ICG in the tumor region. In conclusion, ICG@CQD is proposed as an innovative nanocarrier with great potential for PDT and diagnosis.
期刊介绍:
Journal of Drug Targeting publishes papers and reviews on all aspects of drug delivery and targeting for molecular and macromolecular drugs including the design and characterization of carrier systems (whether colloidal, protein or polymeric) for both vitro and/or in vivo applications of these drugs.
Papers are not restricted to drugs delivered by way of a carrier, but also include studies on molecular and macromolecular drugs that are designed to target specific cellular or extra-cellular molecules. As such the journal publishes results on the activity, delivery and targeting of therapeutic peptides/proteins and nucleic acids including genes/plasmid DNA, gene silencing nucleic acids (e.g. small interfering (si)RNA, antisense oligonucleotides, ribozymes, DNAzymes), as well as aptamers, mononucleotides and monoclonal antibodies and their conjugates. The diagnostic application of targeting technologies as well as targeted delivery of diagnostic and imaging agents also fall within the scope of the journal. In addition, papers are sought on self-regulating systems, systems responsive to their environment and to external stimuli and those that can produce programmed, pulsed and otherwise complex delivery patterns.